Covered recipient · General Payments record
EMILY H MEBRUER
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,065.65
- Reported across 77 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $151.61 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $43.06 | 2 |
| Lilly USA, LLC | $37.63 | 2 |
| Abbott Laboratories | $21.33 | 1 |
| Otsuka America Pharmaceutical, Inc. | $19.83 | 1 |
| Phathom Pharmaceuticals, Inc. | $16.38 | 1 |
| Acerta Pharma LLC | $13.38 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.33 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125332844 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.38 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104335776 | CMS |
| Lilly USA, LLC | $19.17 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136158229 | CMS |
| Lilly USA, LLC | $18.46 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134971336 | CMS |
| Novo Nordisk Inc | $20.73 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096889348 | CMS |
| Novo Nordisk Inc | $22.33 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096917048 | CMS |
| Otsuka America Pharmaceutical, Inc. | $19.83 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118940652 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.38 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151095555 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.